A detailed history of Veriti Management LLC transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Veriti Management LLC holds 4,291 shares of LH stock, worth $869,914. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,291
Previous 4,191 2.39%
Holding current value
$869,914
Previous $952,000 1.58%
% of portfolio
0.07%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$209.01 - $232.56 $20,901 - $23,256
100 Added 2.39%
4,291 $937,000
Q4 2023

Feb 05, 2024

BUY
$197.69 - $227.29 $8,302 - $9,546
42 Added 1.01%
4,191 $952,000
Q3 2023

Oct 27, 2023

BUY
$201.05 - $221.7 $6,232 - $6,872
31 Added 0.75%
4,149 $834,000
Q2 2023

Jul 13, 2023

BUY
$211.93 - $241.33 $7,205 - $8,205
34 Added 0.83%
4,118 $993,000
Q1 2023

Apr 26, 2023

SELL
$213.32 - $257.83 $49,276 - $59,558
-231 Reduced 5.35%
4,084 $936,000
Q4 2022

Jan 20, 2023

SELL
$203.72 - $248.97 $39,929 - $48,798
-196 Reduced 4.34%
4,315 $0
Q3 2022

Oct 26, 2022

BUY
$204.81 - $262.19 $96,670 - $123,753
472 Added 11.69%
4,511 $924,000
Q2 2022

Jul 18, 2022

BUY
$213.86 - $277.87 $33,576 - $43,625
157 Added 4.04%
4,039 $947,000
Q1 2022

Apr 11, 2022

BUY
$259.82 - $298.18 $131,209 - $150,580
505 Added 14.95%
3,882 $1.02 Million
Q3 2021

Oct 08, 2021

BUY
$274.82 - $308.34 $196,221 - $220,154
714 Added 26.81%
3,377 $950,000
Q2 2021

Jul 13, 2021

BUY
$251.87 - $278.14 $243,054 - $268,405
965 Added 56.83%
2,663 $735,000
Q1 2021

Apr 14, 2021

BUY
$204.88 - $255.03 $5,531 - $6,885
27 Added 1.62%
1,698 $433,000
Q4 2020

Feb 11, 2021

BUY
$186.91 - $214.42 $312,326 - $358,295
1,671 New
1,671 $340,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $18.2B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Veriti Management LLC Portfolio

Follow Veriti Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.